RecruitingPhase 2NCT07804615
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
Sponsor: Vima Therapeutics
Arlington, VA · +28 more sites